Cargando…
Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer’s perspective
Continued advances in microarray patch (MAP) technology are starting to make needle-free delivery of a broad range of vaccines an achievable goal. The drivers and potential benefits of a MAP platform for pandemic response and routine vaccination are clear and include dose-sparing, cold-chain elimina...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196745/ https://www.ncbi.nlm.nih.gov/pubmed/35356872 http://dx.doi.org/10.1080/21645515.2022.2050123 |